-
1
-
-
0031930567
-
Rifampicin-associated acute renal failure: Pathophysiologic, immunologic, and clinical features
-
De Vriese AS, Robbrecht DL, Vanholder RC, Vogelaers DP, Lameire NH: Rifampicin-associated acute renal failure: Pathophysiologic, immunologic, and clinical features. Am J Kidney Dis 31:108-115, 1998
-
(1998)
Am J Kidney Dis
, vol.31
, pp. 108-115
-
-
De Vriese, A.S.1
Robbrecht, D.L.2
Vanholder, R.C.3
Vogelaers, D.P.4
Lameire, N.H.5
-
2
-
-
0031950382
-
Rifampicin-induced acute renal failure: A series of 60 patients
-
Covic A, Goldsmith DJ, Segall L, et al: Rifampicin-induced acute renal failure: A series of 60 patients. Nephrol Dial Transplant 13:924-929, 1998
-
(1998)
Nephrol Dial Transplant
, vol.13
, pp. 924-929
-
-
Covic, A.1
Goldsmith, D.J.2
Segall, L.3
-
3
-
-
0033171038
-
Acute renal failure and hepatitis induced by intermittent rifampicin therapy
-
Pandey VP, Taneja S, Talati R: Acute renal failure and hepatitis induced by intermittent rifampicin therapy. J Assoc Physicians India 47:837, 1999
-
(1999)
J Assoc Physicians India
, vol.47
, pp. 837
-
-
Pandey, V.P.1
Taneja, S.2
Talati, R.3
-
4
-
-
0016769024
-
Renal failure during intermittent rifampicin therapy
-
Chan WC, O'Mahoney MG, Yu DYC, Yu RYH: Renal failure during intermittent rifampicin therapy. Tubercle 56: 191-198, 1975
-
(1975)
Tubercle
, vol.56
, pp. 191-198
-
-
Chan, W.C.1
O'Mahoney, M.G.2
Yu, D.Y.C.3
Yu, R.Y.H.4
-
5
-
-
0020572477
-
Acute renal failure due to continuous rifampicin
-
Power DA, Russell G, Smith FW, et al: Acute renal failure due to continuous rifampicin. Clin Nephrol 20:155-159, 1983
-
(1983)
Clin Nephrol
, vol.20
, pp. 155-159
-
-
Power, D.A.1
Russell, G.2
Smith, F.W.3
-
6
-
-
0021722422
-
Reversible acute renal failure due to monthly administration of rifampicin in a leprosy patient
-
Kar HK, Roy RG: Reversible acute renal failure due to monthly administration of rifampicin in a leprosy patient. Indian J Lepr 56:835-839, 1984
-
(1984)
Indian J Lepr
, vol.56
, pp. 835-839
-
-
Kar, H.K.1
Roy, R.G.2
-
7
-
-
0023226461
-
Papillary necrosis associated with rifampicin therapy
-
Lai FM, Lai KN, Chong YW: Papillary necrosis associated with rifampicin therapy. Aust NZ J Med 17:68-70, 1987
-
(1987)
Aust NZ J Med
, vol.17
, pp. 68-70
-
-
Lai, F.M.1
Lai, K.N.2
Chong, Y.W.3
-
8
-
-
0031952099
-
Crescentic glomerulonephritis due to rifampin treatment in a patient with pulmonary atypical mycobacteriosis
-
Ogata H, Kubo M, Tamaki K, et al: Crescentic glomerulonephritis due to rifampin treatment in a patient with pulmonary atypical mycobacteriosis. Nephron 78:319-322, 1998
-
(1998)
Nephron
, vol.78
, pp. 319-322
-
-
Ogata, H.1
Kubo, M.2
Tamaki, K.3
-
9
-
-
0016863688
-
Permanent renal damage with rifampicin
-
letter
-
Cochran M, Morrhead PJ, Platts M: Permanent renal damage with rifampicin. Lancet 1:1428, 1975 (letter)
-
Lancet
, vol.1
, pp. 1428
-
-
Cochran, M.1
Morrhead, P.J.2
Platts, M.3
-
10
-
-
0034126618
-
Minimal change nephrotic syndrome associated with rifampicin treatment
-
Kohno K, Mizuta Y, Yoshida T, et al: Minimal change nephrotic syndrome associated with rifampicin treatment. Nephrol Dial Transplant 15:1056-1059, 2000
-
(2000)
Nephrol Dial Transplant
, vol.15
, pp. 1056-1059
-
-
Kohno, K.1
Mizuta, Y.2
Yoshida, T.3
-
11
-
-
0015214054
-
Potentially serious side effects of high-dose twice-weekly rifampicin
-
Poole G, Stradling P, Worlledge S: Potentially serious side effects of high-dose twice-weekly rifampicin. BMJ 3:343-347, 1971
-
(1971)
BMJ
, vol.3
, pp. 343-347
-
-
Poole, G.1
Stradling, P.2
Worlledge, S.3
-
12
-
-
0010585267
-
-
New Delhi, India, Directorate General of Health Services
-
Tuberculosis: A Guide for Practicing Physicians. New Delhi, India, Directorate General of Health Services, 1995, pp 1-35
-
(1995)
Tuberculosis: A Guide for Practicing Physicians
, pp. 1-35
-
-
-
13
-
-
0033374989
-
Progress towards elimination of leprosy as a public health problem in India and role of modified leprosy elimination campaign
-
Dharmshaktu N, Barkakaty B, Patnaik P, Arif M: Progress towards elimination of leprosy as a public health problem in India and role of modified leprosy elimination campaign. Lepr Rev 70:430-439, 1999
-
(1999)
Lepr Rev
, vol.70
, pp. 430-439
-
-
Dharmshaktu, N.1
Barkakaty, B.2
Patnaik, P.3
Arif, M.4
-
14
-
-
0019953991
-
Antirifampicin antibodies in acute rifampicin-associated renal failure
-
Mauri JM, Fort J, Bartolome J, et al: Antirifampicin antibodies in acute rifampicin-associated renal failure. Nephron 31:177-179, 1982
-
(1982)
Nephron
, vol.31
, pp. 177-179
-
-
Mauri, J.M.1
Fort, J.2
Bartolome, J.3
-
15
-
-
0026664987
-
Intravascular hemolysis and acute renal failure following intermittent rifampin therapy
-
Gupta A, Sakhuja V, Gupta KL, Chugh KS: Intravascular hemolysis and acute renal failure following intermittent rifampin therapy. Int J Lepr Other Mycobact Dis 60:185-188, 1992
-
(1992)
Int J Lepr Other Mycobact Dis
, vol.60
, pp. 185-188
-
-
Gupta, A.1
Sakhuja, V.2
Gupta, K.L.3
Chugh, K.S.4
-
16
-
-
0023262703
-
Rapidly progressive glomerulonephritis associated with rifampicin therapy for pulmonary tuberculosis
-
Murray AN, Cassidy MJ, Templecamp C: Rapidly progressive glomerulonephritis associated with rifampicin therapy for pulmonary tuberculosis. Nephron 46:373-376, 1987
-
(1987)
Nephron
, vol.46
, pp. 373-376
-
-
Murray, A.N.1
Cassidy, M.J.2
Templecamp, C.3
-
17
-
-
0027986909
-
Crescentic fibrillary glomerulonephritis associated with intermittent rifampin therapy for pulmonary tuberculosis
-
Kohler LJ, Gohara AF, Hamilton RW, Reeves RS: Crescentic fibrillary glomerulonephritis associated with intermittent rifampin therapy for pulmonary tuberculosis. Clin Nephrol 42:263-265, 1994
-
(1994)
Clin Nephrol
, vol.42
, pp. 263-265
-
-
Kohler, L.J.1
Gohara, A.F.2
Hamilton, R.W.3
Reeves, R.S.4
-
18
-
-
0020641356
-
Rapidly progressive glomerulonephritis during antituberculous therapy
-
Hirsch DJ, Bia FJ, Kashgarian M, Bia MJ: Rapidly progressive glomerulonephritis during antituberculous therapy. Am J Nephrol 3:7-10, 1983
-
(1983)
Am J Nephrol
, vol.3
, pp. 7-10
-
-
Hirsch, D.J.1
Bia, F.J.2
Kashgarian, M.3
Bia, M.J.4
-
19
-
-
0034911861
-
Drug-induced acute interstitial nephritis
-
Rossert J: Drug-induced acute interstitial nephritis. Kidney Int 60:804-817, 2001
-
(2001)
Kidney Int
, vol.60
, pp. 804-817
-
-
Rossert, J.1
-
20
-
-
0018123267
-
Identification of I/i, Pr1-3 and Gd antigens in the human kidney: Possible relevance to hyperacute graft rejection induced by cold agglutinins
-
Lenhard V, Seelig HP, Geisen HP, Roelcke D: Identification of I/i, Pr1-3 and Gd antigens in the human kidney: Possible relevance to hyperacute graft rejection induced by cold agglutinins. Clin Exp Immunol 33:276-282, 1978
-
(1978)
Clin Exp Immunol
, vol.33
, pp. 276-282
-
-
Lenhard, V.1
Seelig, H.P.2
Geisen, H.P.3
Roelcke, D.4
-
21
-
-
0025799437
-
Immune hemolytic anemia and renal failure associated with rifampicin-dependent antibodies with anti-I specificity
-
Pereira A, Sanz C, Cervantes F, Castillo R: Immune hemolytic anemia and renal failure associated with rifampicin-dependent antibodies with anti-I specificity. Ann Hematol 63:56-58, 1991
-
(1991)
Ann Hematol
, vol.63
, pp. 56-58
-
-
Pereira, A.1
Sanz, C.2
Cervantes, F.3
Castillo, R.4
-
22
-
-
0002097371
-
Drug-related immune hemolytic anemia
-
Beutler E, Lichtman MA, Coller BS, Kipps TJ (eds). New York, NY, McGraw-Hill
-
Packman CH, Leddy JP: Drug-related immune hemolytic anemia, in Beutler E, Lichtman MA, Coller BS, Kipps TJ (eds): Williams Hematology (ed 5). New York, NY, McGraw-Hill, 1995, pp 691-697
-
(1995)
Williams Hematology (ed 5)
, pp. 691-697
-
-
Packman, C.H.1
Leddy, J.P.2
-
23
-
-
0017300664
-
Tubulointerstitial and glomerular nephritis associated with rifampin. Report of a case
-
Gabow PA, Lacher JW, Neff TA: Tubulointerstitial and glomerular nephritis associated with rifampin. Report of a case. JAMA 235:2517-2518, 1976
-
(1976)
JAMA
, vol.235
, pp. 2517-2518
-
-
Gabow, P.A.1
Lacher, J.W.2
Neff, T.A.3
-
24
-
-
0021889565
-
Absence from sera from normal individuals or from rifampin-treated leprosy patients (THELEP trials) of antibody to rifamycin-protein or rifamycin-membrane conjugates
-
Rook GA: Absence from sera from normal individuals or from rifampin-treated leprosy patients (THELEP trials) of antibody to rifamycin-protein or rifamycin-membrane conjugates. Int J Lepr Other Mycobact Dis 53:22-27, 1985
-
(1985)
Int J Lepr Other Mycobact Dis
, vol.53
, pp. 22-27
-
-
Rook, G.A.1
-
25
-
-
0021813680
-
Reduced complement-mediated immune complex solubilization in leprosy patients
-
Ramanathan VD, Sharma P, Ramu G, Sengupta U: Reduced complement-mediated immune complex solubilization in leprosy patients. Clin Exp Immunol 60:553-558, 1985
-
(1985)
Clin Exp Immunol
, vol.60
, pp. 553-558
-
-
Ramanathan, V.D.1
Sharma, P.2
Ramu, G.3
Sengupta, U.4
|